Rationale

Target Malaria began its engagement at an early stage of the research as the project appreciated it is essential that those who could be impacted are informed and consulted, not simply when the intervention is ready, but during the development phase as well.

Alongside regulatory authorities, stakeholders will be the ones to decide if our genetic technologies can be evaluated in the field. Engaging with them ensures that these technologies, and our project activities, are accurately and honestly communicated to all, and most importantly to the potential beneficiaries of this research in Africa.

Target Malaria is listening to concerns and responding to questions about gene drive technology. We also believe that it is important that the development of this potentially life-saving technology is not stifled due to misinformation.